Phibro Animal Health Corp. A Stock
Phibro Animal Health Corp. A gained 1.200% today.
Our community is currently high on Phibro Animal Health Corp. A with 5 Buy predictions and 2 Sell predictions.
However, we have a potential of -31.95% for Phibro Animal Health Corp. A as the target price of 23 € is below the current price of 33.8 €.
Pros and Cons of Phibro Animal Health Corp. A in the next few years
Pros
?
C******** o* t** e**********
?
W********* I********* f** t** n*** y****
?
G***** c******* t* c**********
Cons
?
B****
?
S********** s********
?
M***** P*******
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Phibro Animal Health Corp. A vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Phibro Animal Health Corp. A | 1.200% | 6.962% | 0.595% | 62.500% | 6.962% | 166.142% | 101.190% |
| Rockwell Medical Inc. | -3.830% | 13.833% | 2.605% | -58.897% | 22.247% | -37.820% | -91.457% |
| Pacira Pharmaceuticals | -8.110% | 7.767% | 5.714% | 25.424% | 2.778% | -34.706% | -61.724% |
| Twist Bioscience Corp | 0.230% | 9.837% | 11.042% | -30.567% | 9.048% | 22.287% | -78.307% |
Comments
Phibro Animal Health (NASDAQ:PAHC) had its price target raised by analysts at JPMorgan Chase & Co. from $45.00 to $50.00. They now have an "overweight" rating on the stock.
Show more
Ratings data for PAHC provided by MarketBeat
Phibro Animal Health (NASDAQ:PAHC) had its price target raised by analysts at Bank of America Corporation from $19.00 to $27.00. They now have an "underperform" rating on the stock.
Show more
Ratings data for PAHC provided by MarketBeat
Phibro Animal Health Corporation (NASDAQ: PAHC) was upgraded by analysts at JPMorgan Chase & Co. from a "neutral" rating to an "overweight" rating. They now have a $35.00 price target on the stock, up previously from $25.00.
Show more
Ratings data for PAHC provided by MarketBeat